Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-155-6 | CAS number: 91844-86-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Artemisia pallens, Compositae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
- Ames Test (OECD 471, GLP, K, rel. 1): non mutagenic up to cytotoxic concentration in S. typhimurium TA 1535, TA 1537, TA 98, TA 100 & E.coli WP2uvrA.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2017-02-08 to 2017-03-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 471 and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- QA statement signed on 2017-04-20
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine gene for Salmonella and tryptophan gene for E.coli
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: The bacterial strains were acquired by Gentronix Ltd, BioHub at Alderley Park, from the AstraZeneca (AZ) Genetic Toxicology Department, Alderley Park, UK. AZ acquired the strains from the following sources:
*TA1535, TA1537 and TA100 were originally obtained in 1995 by AZ Sweden, from Professor B N Ames, Biochemistry Department, University of California, Berkeley, California, USA.
*TA98 was originally obtained in 2008 by AZ Sweden, from BioReliance Corporation, Rockville, Maryland, USA.
*The E. coli strain was originally obtained in 1995 by AZ Sweden, from Dr S Venitt, Institute of Cancer Research, Royal Marsden Hospital, Surrey, UK.
The bacteria were stored frozen at approximately -196°C after sub-culturing; master cultures
were stored frozen at approximately -196°C after sub-culturing. Before establishing cryopreserved working stock cultures and on the day of the first mutagenicity test, the strains were checked for the following characteristics (phenotype check): absence of contamination; spontaneous revertant frequency; pre-existing revertant numbers; presence of the deep rough (rfa) marker (not uvrA/pKM101); sensitivity to UV light; presence of plasmid pKM101 (TA98, TA100 and uvrA/pKM101).
CULTURE MEDIA
The medium used for the growth of all inoculum cultures was Nutrient Broth No.2 (Oxoid Limited)
supplemented with ampicillin, as required. Test systems were plated onto a minimal glucose agar
medium (Vögel-Bonner agar) prepared by the VWR Scientific Preparation Laboratory, Alderley
Park, UK. - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: The post-mitochondrial fraction (S9) of a rat liver homogenate was purchased from Molecular Toxicology Inc. (Boone, North Carolina, USA) via TRiNOVA Biochem GmbH, Germany. The S9 was prepared from the livers of male Sprague-Dawley rats treated with Aroclor 1254. Its metabolic capacity was demonstrated by key enzyme assays and the ability to activate reference agents to bacterial mutagens. Furthermore, because of batch to batch variation and to assess suitability for use in this laboratory, each lot of S9 will have undergone in-house testing using two promutagens, cyclophosphamide and benzo[a]pyrene (TA1535 and TA98, respectively). The protein content was adjusted to 30 mg/mL by dilution with 0.1 mol/L phosphate buffer (pH7.4) before incorporation into the S9 mix.
- method of preparation of S9 mix: The S9 fraction was stored deep-frozen in a -80°C freezer. Sufficient vials were removed from frozen, thawed and used; any excess S9 fraction was discarded. The complete activation system (S9 mix) was prepared immediately before use; final concentrations in the S9 mix were as follows:
S9 10% v/v
Phosphate buffer (0.1 mol/L, pH 7.4) 100 mmol/L
Magnesium chloride 8 mmol/L
Potassium chloride 33 mmol/L
Nicotinamide adenine dinucleotide phosphate 4 mmol/L
Glucose-6-phosphate 5 mmol/L
- concentration of S9 in the final culture medium: 10%
- quality controls of S9: sterility, metabolic capability - Test concentrations with justification for top dose:
- - Experiment 1 (+/- S9): 1.6, 5, 16, 50, 160, 500, 1600 and 5000 µg/plate (up to maximum recommended concentration) for plate incorporation method.
- Experiment 2: 16, 50, 160, 500, 1600 and 5000 µg/plate (up to maximum recommended concentration) for plate incorporation method. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: A preliminary assessment of solubility of the test item in the preferred solvent (vehicle), dimethyl sulphoxide (DMSO), was conducted. As solubility of the test item in DMSO was satisfactory, it was used as the solvent for the mutagenicity testing.
- The test item was administered in solvent, dimethyl sulphoxide (DMSO) at a volume of 100 μL per plate, within four hours of formulation for mutagenicity test 1 and within three hours of formulation for mutagenicity test 2. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- In the presence of S9-mix
- Positive control substance:
- benzo(a)pyrene
- other: 2-aminoanthracene: 2 µg/plate for TA98, TA100, TA1537 and TA1535 and 20 µg/plate for uvrA/pKM101
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- In the absence of S9-mix
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- other: 9-Aminoacridine.HCl and Potassium dichromate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: In all cases there were three plates in the solvent (DMSO) control, test item and positive control groups.
- Number of independent experiments: Two independent plate incorporation mutagenicity tests were performed using Salmonella typhimurium LT2 strains TA1535, TA1537, TA98 and TA100, and Escherichia coli WP2 strain uvrA/pKM101, in both the presence and absence of S9 mix.
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in agar (plate incorporation): both experiments
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: Briefly, frozen aliquots of the bacterial strains (-70°C or lower) were incubated overnight (8 to 10 hours) at 37°C in an orbital incubator (120 rpm) in nutrient broth. For strains TA98, TA100 and uvrA/pKM101, the nutrient broth was supplemented with ampicillin at 25 µg/mL.
- Exposure duration/duration of treatment: 48-72 hours (3 days at 37°C)
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: background growth inhibition
After incubation at 37°C for 3 days, all plates were examined both macroscopically and microscopically for evidence of cytotoxicity, precipitates and any other effect relevant to the interpretation of the test. Microscopic examination was used to check the condition of the histidine/tryptophan-requiring microcolonies that make up the ‘background lawns’.
Revertant (his+, trp+) colony numbers were scored using a Sorcerer Colony Counter (Perceptive Instruments, UK). In cases where the mean incidence of revertant colonies on the solvent control plates was 20 or less (typically with strains TA1535 and TA1537), or if cytotoxicity or precipitate interfered with image analysis, the plates were scored manually. All counts were manually entered into the results sheet.
CHECK
- Sterility Controls: Plates containing each component of the test system except the bacteria were included to check against possible accidental contamination of the system.
- Viability Determination: Confirmation that adequate numbers of viable bacteria were exposed to the test item was obtained from viability determinations for each strain performed concurrently with the mutagenicity test. - Rationale for test conditions:
- Tested up to maximum recommended concentration or up to cytoxicity.
- Evaluation criteria:
- TOXICITY
A dose of the test item was judged to be toxic to a bacterial strain if the formation of
microcolonies (background lawn) was reduced, or a decrease in the number of revertant colonies
was seen.
MUTAGENICITY
A test item was considered to be mutagenic if the following criteria were satisfied:
1. For TA1535 or TA1537, the mean number of revertant colonies of one or more doses of the test item, with or without metabolic activation was equal to or greater than 2 times the concurrent solvent control mean value and the relevant historical mean value; for any other strain, the mean number of revertant colonies was equal to or greater than 2 times the concurrent solvent control mean value in the presence of one or more doses of the test item, with or without metabolic activation.
2. There was a dose-related increase in the number of revertant colonies.
3. Any increase was reproducible. - Statistics:
- Not reported
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above 500 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above 500 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above 500 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above 500 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above 1600 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above a dose of 160 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above a dose of 160 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above a dose of 160 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at and above a dose of 160 μg per plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- FORMULATION ANALYSIS
In accordance with the regulatory test guidelines, no analyses of the stability of the test item in administered formulations or dilutions were undertaken as fresh solutions were prepared on the day of use and each mutagenicity test was dosed within four hours of formulation for mutagenicity test 1 and within three hours of formulation for mutagenicity test 2.
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation and time of the determination: Precipitate was seen at and above a dose of 500 μg per plate in both the presence and absence of S9 mix on the day of dosing, and at and above 1600 μg per plate in both the presence and absence of S9 mix on the day of scoring.
- controls: The mean solvent control (DMSO) revertant numbers were within the acceptable ranges for each of the indicator strains. The results obtained with positive control agents demonstrated the mutability of the individual strains and, where appropriate, the ability of the S9 mix to metabolise 2-aminoanthracene. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The sterility controls were all free from contamination and the viability determination confirmed that adequate numbers of viable bacteria of each strain were exposed to the test item. Phenotypes of bacterial indicator strains were confirmed.
STUDY RESULTS
Experiment 1 (plate incorporation):
Based on current OECD guidelines, the dose range selected was 1.6 to 5000 μg per plate in both the presence and absence of S9 mix.
Precipitate was seen at and above a dose of 500 μg per plate in both the presence and absence of S9 mix on the day of dosing, and at and above 1600 μg per plate in both the presence and absence of S9 mix on the day of scoring.
Evidence of cytotoxicity as indicated by reductions in the growth of the background lawns or in the incidence of spontaneous revertant colonies was seen at and above a dose of 160 μg per plate for the four S. typhimurium strains in the absence of S9 mix, at and above 500 μg per plate for the four S. typhimurium strains in the presence of S9 mix, and at and above 1600 μg per plate for the E. coli strain in both the presence and absence of S9 mix. Due to excessive cytotoxicity, plates could not be scored for numbers of revertant colonies at 5000 μg per plate for the four S. typhimurium strains in the presence and absence of S9 mix.
No significant increase in numbers of revertant (histidine or tryptophan-independent) colonies was seen with any of the five indicator strains either in the presence or absence of S9 mix.
Experiment 2 (plate incorporation):
Based on findings in mutagenicity test 1, the dose range selected was 16 to 5000 μg per plate in both the presence and absence of S9 mix.
Precipitate was seen at and above a dose of 500 μg per plate in both the presence and absence of S9 mix on the day of dosing, and at and above 1600 μg per plate in both the presence and absence of S9 mix on the day of scoring.
Evidence of cytotoxicity as indicated by reductions in the growth of the background lawns or in the incidence of spontaneous revertant colonies was seen at and above a dose of 160 μg per plate for the four S. typhimurium strains in the absence of S9 mix, at and above 500 μg per plate for the four S. typhimurium strains in the presence of S9 mix, and at and above 1600 μg per plate for the E. coli strain in both the presence and absence of S9 mix. Due to excessive cytotoxicity, plates could not be scored for numbers of revertant colonies at 5000 μg per plate for the four S. typhimurium strains in the presence and absence of S9 mix.
No significant increase in numbers of revertant (histidine or tryptophan-independent) colonies was seen with any of the five indicator strains either in the presence or absence of S9 mix.
HISTORICAL CONTROL DATA
- Positive historical control data: cf. attached document
- Negative (solvent/vehicle): cf. attached document - Conclusions:
- In this Reverse Mutation Assay ‘Ames Test’ using strains of Salmonella typhimurium and Escherichia coli the test item did not induce an increase in the frequency of revertant colonies at any of the dose levels used either with or without metabolic activation (S9-mix). Under the conditions of this test, it was concluded that Davana Oil was not mutagenic using a plate incorporation method for Salmonella typhimurium LT2 strains TA1535, TA1537, TA98 and TA100, and Escherichia coli WP2 strain uvrA/pKM101, either in the presence or absence of S9 mix, when tested under the conditions used in this assay.
- Executive summary:
In a reverse gene mutation assay in bacteria, Salmonella typhimurium LT2 bacteria strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA/pKM101 as indicator organisms were treated with the test item using the Ames plate incorporation method at up to eight dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolizing system (10% liver S9 in standard co-factors), according to the OECD TG 471 guideline and the methods of Maron and Ames, 1983, Venitt et al., 1984, Mortelmans and Zeiger, 2000 and Mortelmans and Riccio, 2000.
A preliminary assessment of solubility was performed to determine suitable dose levels of Davana Oil for the mutagenicity tests.
The dose ranges used were:
Mutagenicity test 1: 1.6 to 5000 μg per plate
Mutagenicity test 2: 16 to 5000 μg per plateThe mean solvent control (DMSO) revertant numbers were within the acceptable ranges for each of the indicator strains. The results obtained with positive control agents demonstrated the mutability of the individual strains and, where appropriate, the ability of the S9 mix to metabolise 2-aminoanthracene. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
The sterility controls were all free from contamination and the viability determination confirmed that adequate numbers of viable bacteria of each strain were exposed to the test item. Phenotypes of bacterial indicator strains were confirmed.The test item showed evidence of cytotoxicity to the bacteria. The minimum dose showing evidence of cytotoxicity was 160 μg per plate. The maximum dose level scored for revertant colonies was 5000 μg per plate. The minimum dose at which precipitate was seen on the day of scoring was 1600 μg per plate.
No significant increase in numbers of revertant (histidine or tryptophan-independent) colonies was seen with any of the five indicator strains either in the presence or absence of S9 mix.In this Reverse Mutation Assay ‘Ames Test’ using strains of Salmonella typhimurium and Escherichia coli the test item did not induce an increase in the frequency of revertant colonies that met the criteria for a positive result, at any of the dose levels used either with or without metabolic activation (S9-mix).
Under the conditions of this test, it was concluded that Davana Oil was not mutagenic using a plate incorporation method for Salmonella typhimurium LT2 strains TA1535, TA1537, TA98 and TA100, and Escherichia coli WP2 strain uvrA/pKM101, either in the presence or absence of S9 mix, when tested under the conditions used in this assay. This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.
Reference
See tables of result attached in the "attached background material" section.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Table 7.6/1: Summary of genotoxicity tests
Test n° | Test / Guideline Reliability | Focus | Strains tested | Metabolic activation | Test concentration | Statement |
1
Gentronix, 2017 | Ames Test (OECD 471) K, rel. 1 | Gene mutation | TA 1535, TA 1537, TA 98, TA 100 E. coli WP2uvrA | -S9 +S9 | Up to cytotoxic concentration | -S9 : non mutagenic +S9 : non mutagenic |
Gene mutation Assays (Tests n° 1):
A Bacterial Reverse mutation Assay (Ames test) was performed according to OECD guideline No. 471 with the substance (see Table 7.6/1). No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains under the test condition, with any dose of the substance, either in the presence or absence of metabolic activation. The substance does not induce gene mutations in bacteria whereas all positive control chemicals (with and without metabolic activation) induced significant increase of colonies. The substance is therefore considered as non-mutagenic according to the Ames test.
Justification for classification or non-classification
Harmonized classification:
The test material has no harmonized classification for human health according to the Regulation (EC) No. 1272/2008 (CLP).
Self-classification:
Based on the available data, no additional classification is proposed regarding germ cell mutagenicity according to the CLP and the GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.